Zoledronic acid decreases mRNA six-transmembrane epithelial antigen of prostate protein expression in prostate cancer cells.

Journal of Endocrinological Investigation
M T ValentiL Dalle Carbonare

Abstract

Zoledronic acid (Zol) is used successfully to inhibit bone resorption in tumor bone disease of various human cancer. Zol inhibits the mevalonate pathway and other potential targets include the inhibition of tyrosine phosphatase activity, disruption of metalloproteinase, secretion and down-regulation of the catalytic subunit of telomerase (hTERT). The six-transmembrane epithelial antigen of prostate protein (STEAP) is a new marker highly expressed at all phases of prostate cancer. Here, we analyzed for the first time the effect of Zol on STEAP gene expression in prostate cancer cells. We evaluated the effects of Zol in STEAP gene expression by RT real time PCR in androgen-sensitive (LNCaP) and androgen-non-sensitive (PC3 and DU145) cell lines. To confirm the pro-apoptotic effect of Zol, we also analyzed the caspase-3 gene expression, that resulted up-regulated in cancer cell apoptosis. Zol strongly decreased cell viability and lowered STEAP gene expression in a dose-dependent manner. In addition, this effect was accompanied by an increase of apoptotic index and an up-regulation of caspase-3 gene expression. Zol may affect cancer cells also by targeting the gene expression of STEAP.

References

Oct 1, 1995·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·E L LevineR D Hunter
Oct 1, 1996·Genome Research·C A HeidP M Williams
Apr 29, 1998·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·S P LuckmanM J Rogers
Dec 10, 1999·Proceedings of the National Academy of Sciences of the United States of America·R S HubertD E Afar
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
May 28, 2004·Endocrine-related Cancer·Janet E BrownRobert E Coleman
Dec 30, 2004·BMC Cancer·Luis Sanchez-PulidoMiguel A Andrade
May 5, 2007·Cell Death and Differentiation·N PrevarskayaY Shuba
May 18, 2007·Journal of Cellular Physiology·V SamannaM A Chellaiah
Nov 27, 2007·European Journal of Pharmacology·Maria Teresa ValentiVincenzo Lo Cascio
Apr 26, 2008·Apoptosis : an International Journal on Programmed Cell Death·Lilian SewingRüdiger Göke
Sep 17, 2008·Cancer Letters·M T ValentiV Lo Cascio
Jul 22, 2009·International Journal of Cancer. Journal International Du Cancer·Andreas GuentherMartin Gramatzki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.